NOMINATION AND VOTING AGREEMENTNomination and Voting Agreement • October 18th, 2017 • ACM Research, Inc. • Special industry machinery, nec • Delaware
THIS NOMINATION AND VOTING AGREEMENT (this “Agreement”), dated as of October 11, 2017, is made by and among ACM Research, Inc., a Delaware corporation (the “Company”), Xinxin (Hongkong) Capital Co., Limited (the “Holder”), and the several individuals and entities named on SCHEDULE I (the “Voting Holders”). Certain capitalized terms used herein are defined in Section 1.
CESCA THERAPEUTICS INC. FIRST AMENDED AND RESTATED NOMINATION AND VOTING AGREEMENTNomination and Voting Agreement • April 18th, 2018 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • California
This First Amended and Restated Nomination and Voting Agreement (this “Agreement”) is made as of April 16, 2018 by and between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and Boyalife (Hong Kong) Limited (“Investor”). The Company and the Investor are referred to herein collectively as, the “Parties”. This Agreement amends and restates that certain Nomination and Voting Agreement originally entered into by the Parties and Boyalife Investment Inc. (“Boyalife USA”) on February 13, 2016 (the “Original Agreement”).
DIRECTOR NOMINATION AND VOTING AGREEMENTNomination and Voting Agreement • June 4th, 2021 • Alkuri Global Acquisition Corp. • Blank checks • New York
THIS DIRECTOR NOMINATION AGREEMENT (this “Agreement”) is made and entered into as of June 3, 2021 (the “Effective Time”), by and between by and between Babylon Holdings Limited, a company limited by shares incorporated under the laws of Jersey with registered number 115471 (“Company”), and Works Capital LLC (the “SPAC Affiliate”). Capitalized terms used but not otherwise defined in this Agreement have the respective meanings given to them in the Merger Agreement (as defined below).
NOMINATION AND VOTING AGREEMENTNomination and Voting Agreement • April 24th, 2009 • International Royalty Corp • Ontario
DOUGLAS SILVER, Chief Executive Officer of the Corporation, DOUGLAS HURST, President of the Corporation and GEORGE YOUNG, general counsel of the Corporation,
CESCA THERAPEUTICS INC. NOMINATION AND VOTING AGREEMENTNomination and Voting Agreement • February 3rd, 2016 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • California
This Nomination and Voting Agreement (this “Agreement”) is made as of [●], 2016 by and among Cesca Therapeutics Inc., a Delaware corporation (the “Company”) Boyalife Investment Inc. (“Boyalife USA”), and Boyalife (Hong Kong) Limited (“Boyalife Hong Kong”). Boyalife USA and Boyalife Hong Kong are each referred to in this Agreement, individually, as an “Investor” and, together, as the “Investors”. The Company and the Investors are referred to herein collectively as, the “Parties”.
